Increased risk of non-Q wave myocardial infarction after directional atherectomy is platelet dependent: Evidence from the EPIC trial

Journal of the American College of Cardiology

Volumn 28, Issue 4, 1996, Pages 849-855

  Lefkovits, Jeffrey ^a   Blankenship, James C ^b   Anderson, Keaven M ^c   Stoner, Gail L ^c   Talley, J David ^d   Worley, Seth J ^e   Weisman, Harlan F ^c   Califf, Robert M ^f   Topol, Eric J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CENTOCOR INC   (United States)

^c GEISINGER MEDICAL CENTER   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^e LANCASTER GENERAL HOSPITAL   (United States)

^f DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; FIBRINOGEN RECEPTOR; FIBRINOGEN RECEPTOR ANTAGONIST; RECEPTOR ANTIBODY;

ADULT; AGED; ARTICLE; ATHERECTOMY; BOLUS INJECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY RISK; DOUBLE BLIND PROCEDURE; FEMALE; HEART INFARCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; Q WAVE; RANDOMIZED CONTROLLED TRIAL; RECEPTOR BLOCKING; RISK BENEFIT ANALYSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

EID: 0030273574     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(96)00239-2     Document Type: Article

References (30)

1. Topol EJ, Leya F, Pinkerton CA, et al. A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. N Engl J Med 1993;329:221-7.
2. Holmes DR, Topol EJ, Califf RM, et al. A multicenter randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions. Circulation 1995;91:1966-74.
3. Adelman A, Cohen E, Kimball B, et al. A comparison of directional atherectomy with balloon angioplasty for lesions of the left anterior descending coronary artery. N Engl J Med 1993;329:228-33.
4. The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956-61.
5. Topol EJ, Califf RM, Weisman HF, et al. Randomized trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. Lancet 1994;343:881-6.
6. Ellis SG, Vandormael MG, Cowley MJ, et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Circulation 1990;82:1193-202.
7. Rao AK, Pratt C, Berke Aet al. Thrombolysis in Myocardial Infarction (TIMI) trial - phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. J Am Coll Cardiol. 11:1988;1-11.
8. Leon MB, Kuntz RE, Popma JJet al. Acute angiographic, intravascular ultrasound and clinical results of directional atherectomy in the Optimal Atherectomy Restenosis Study. [abstract] J Am Coll Cardiol. S25:1995;137A.
9. Baim DS, Kuntz RE, Sharma SKet al. Acute results of the randomized phase of the Balloon versus Optimal Atherectomy Trial (BOAT). [abstract] Circulation. 92(Suppl I):1995;I-544.
10. Safian RD, Gelbfish JS, Erny RE, Schnitt SJ, Schmidt DA, Baim DS Coronary atherectomy. Clinical, angiographic, and histological findings and observations regarding potential mechanisms. Circulation. 82:1990;69-79.
11. Garratt KN, Holmes DR, Bell MR, et al. Results of directional atherectomy of primary atheromatous and restenosis lesions in coronary arteries and saphenous vein grafts. Am J Cardiol 1992;70:449-54.
12. Fishman R, Kuntz R, Carrozza Jr J, et al. Long-term results of directional coronary atherectomy: predictors of restenosis. J Am Coll Cardiol 1992;20: 1101-10.
13. Baim DS, Hinohara T, Holmes DRet al. Results of directional coronary atherectomy during multicenter preapproval testing. Am J Cardiol. 72:1993;6E-11E.
14. Cowley M, DiSciascio G Experience with directional coronary atherectomy since premarket approval. Am J Cardiol. 72:1993;12E-20E.
15. Popma JJ, Topol EJ, Hinohara T, et al. Abrupt vessel closure after directional coronary atherectomy. J Am Coll Cardiol 1992;19:1372-9.
16. Hinohara T, Rowe MH, Robertson GC, et al. Effect of lesion characteristics on outcome of directional coronary atherectomy. J Am Coll Cardiol 1991;17:1112-20.
17. Carrozza J, Baim D Complications of directional coronary atherectomy: incidence, causes, and management. Am J Cardiol. 72:1993;47E-54E.
18. Fernandez-Ortiz A, Badimon JJ, Falk E, et al. Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for plaque rupture. J Am Coll Cardiol 1994;23:1562-9.
19. Badimon L, Badimon JJ, Turitto VT, Vallabhajosula S, Fuster V. Platelet thrombus formation on collagen type I. A model of deep vessel injury. Influence of blood rheology, von Willebrand factor, and blood coagulation. Circulation 1988;78:1431-42.
20. Mailhac A, Badimon JJ, Fallon JT, et al. Effect of an eccentric severe stenosis on fibrin(ogen) deposition on severely damaged vessel wall in arterial thrombosis. Relative contribution of fibrin(ogen) and platelets. Circulation 1994;90:988-96.
21. Kugelmass AD, Cohen DJ, Moscucci M, et al. Elevation of the creatine kinase myocardial isoform following otherwise successful directional coronary atherectomy and stenting. Am J Cardiol 1994;74:748-54.
22. Oh JK, Shub C, Ilstrup DM, Reeder GS. Creatine kinase release after successful percutaneous transluminal coronary angioplasty. Am Heart J 1985;109:1225-31.
23. Klein LW, Kramer BL, Howard E, Lesch M. Incidence and clinical significance of transient creatine kinase elevations and the diagnosis of non-Q wave myocardial infarction associated with coronary angioplasty. J Am Coll Cardiol 1991;17:621-6.
24. Harrington RA, Lincoff AM, Califf RM, et al. Characteristics and consequences of myocardial infarction following percutaneous coronary intervention: insights from CAVEAT. J Am Coll Cardiol 1995;25:1693-9.
25. Abdelmeguid AE, Ellis SG, Sapp SK, Whitlow PL, Topol EJ. Defining the appropriate threshold of creatine kinase elevation after percutaneous coronary interventions. Am Heart J 1996;131:1097-105.
26. Redwood SR, Popma JJ, Kent KMet al. "Minor" CPK-MB elevations are associated with increased late mortality following ablative new-device angioplasty in native coronary arteries. [abstract] Circulation. 92(Suppl I):1995;I-544.
27. Tardiff BE, Granger CB, Woodlief Let al. Prognostic significance of postintervention isozyme elevations. [abstract] Circulation. 92(Suppl I):1995;I-544.
28. Charo IF, Bekeart LS, Phillips DR. Platelet glycoprotein IIb-IIIa-like proteins mediate endothelial cell attachment to adhesive proteins and the extracellular matrix. J Biol Chem 1987;262:9935-8.
29. Altieri DC, Bader R, Mannucci PM, Edgington TS. Oligospecificity of the cellular adhesion receptor Mac-1 encompasses an inducible recognition specificity for fibrinogen. J Cell Biol 1988;107:1893-900.
30. Zhou L, Lee DH, Plescia J, Lau CY, Altieri DC. Differential ligand binding specificities of recombinant CD11b/CD18 integrin I-domain. J Biol Chem 1994;269:17075-9.